NADAL Lyme Borreliosis IgG/IgM, rapid test for detection of anti-Borrelia antibodies

The NADAL Lyme Borreliosis IgG/IgM Rapid Test is a reliable and easy-to-use immunochromatographic test designed for the qualitative detection of anti-Borrelia burgdorferi IgG and IgM antibodies in human serum, plasma, or whole blood. This rapid diagnostic tool enables early detection of Lyme disease, supporting fast clinical decision-making. With results available in just 10–15 minutes, the test is ideal for use in point-of-care settings, laboratories, and clinics. The NADAL test is CE-marked and offers high sensitivity and specificity, ensuring accurate differentiation between IgG (late-stage infection) and IgM (early immune response). This makes it a valuable screening method in Lyme disease diagnostics and monitoring.